scholarly journals Sensitivity of Esophageal Scintigraphy (Milk Scans) in Detecting Gastro-Esophageal Reflux

2015 ◽  
Vol 05 (01) ◽  
pp. 1-9
Author(s):  
Saeed Bafaraj ◽  
Awad Alzahrani
Keyword(s):  
Esophageal Reflux ◽  
Esophageal Scintigraphy

Is one episode enough? Redefining pathologic extra-esophageal reflux

2001 ◽  
Vol 120 (5) ◽  
pp. A422-A422
Author(s):  
L KHAITAN ◽  
E POWITSKY ◽  
J COHEN ◽  
M COUREY ◽  
M HOLZMAN ◽  
...  
Keyword(s):  
Esophageal Reflux

Esophageal Reflux in Simple Heartburn

1955 ◽  
Vol 28 (1) ◽  
pp. 28-33 ◽  
Author(s):  
Charles A. Flood ◽  
Josephine Wells ◽  
Daniel Baker
Keyword(s):  
Esophageal Reflux

Su1146 Intense Gastro-Esophageal Reflux May Influence the Localization of Barrett's Adenocarcinoma: Measured by 24-h pH-Impedance Monitoring

2016 ◽  
Vol 150 (4) ◽  
pp. S483
Author(s):  
Masahiro Saito ◽  
Tomoyuki Koike ◽  
Hiroki Kikuchi ◽  
Kazuaki Norita ◽  
Kenichirou Nakagawa ◽  
...  
Keyword(s):  
Esophageal Reflux ◽  
Barrett’S Adenocarcinoma ◽  
Impedance Monitoring

Ingested Acidic Food and Liquids May Lead to Misinterpretation of 24-Hour Ambulatory pH Tests: Focus on Measurement of Extra-esophageal Reflux

2007 ◽  
Vol 52 (7) ◽  
pp. 1678-1684 ◽  
Author(s):  
Juha W. Koskenvuo ◽  
Jussi P. Pärkkä ◽  
Jaakko J. Hartiala ◽  
Ilpo Kinnunen ◽  
Matti Peltola ◽  
...  
Keyword(s):  
Esophageal Reflux ◽  
Ambulatory Ph

scholarly journals Cancer Prevention in Patients with GERD and Barrett’s Esophagus—Medicine

2021 ◽  
Vol 1 (1) ◽  
pp. 50-62
Author(s):  
Carmelo Scarpignato ◽  
David H. Wang
Keyword(s):  
Risk Factors ◽  
Reactive Oxygen Species ◽  
Cell Proliferation ◽  
Barrett’S Esophagus ◽  
Barrett's Esophagus ◽  
Acid Reflux ◽  
Oxygen Species ◽  
Esophageal Reflux ◽  
Early Disease ◽  
Chemopreventive Agents

Gastro-esophageal reflux disease (GERD) and Barrett’s esophagus are risk factors for esophageal adenocarcinoma (EAC). Chemoprevention is an attractive strategy, more effective than identifying early disease. Since acid reflux can lead to increased cell proliferation, decreased apoptosis, production of reactive oxygen species, DNA damage, and esophageal production of proinflammatory and pro-proliferative cytokines, proton pump inhibitors (PPIs) alone, or in combination with COX-inhibition, are the most suitable chemopreventive agents. Other compounds (statins, metformin, and selected nutraceuticals) cannot currently be recommended. Data are strong enough to warrant PPI treatment of virtually all patients with Barrett’s esophagus, although the best regimen has not yet been defined.

Sign in / Sign up

Export Citation Format

Share Document